Detalhe da pesquisa
1.
Fezolinetant impact on health-related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials.
BJOG
; 2024 Feb 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38320967
2.
Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?: Insights and Perspectives From the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) Addendum.
Value Health
; 26(2): 234-242, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36150999
3.
Psychometric evaluation of the PROMIS SD-SF-8b instrument in individuals experiencing vasomotor symptoms due to menopause.
Health Qual Life Outcomes
; 21(1): 126, 2023 Nov 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37990323
4.
Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause.
Adv Ther
; 41(6): 2233-2252, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38396203
5.
Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause.
Menopause
; 31(1): 68-76, 2024 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38016166
6.
Validation and Application of Thresholds to Define Meaningful Change in Vasomotor Symptoms Frequency: Analysis of Pooled SKYLIGHT 1 and 2 Data.
Adv Ther
; 2024 May 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38775925
7.
Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause.
Maturitas
; : 107999, 2024 May 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38749864
8.
Treating moderate-to-severe menopausal vasomotor symptoms with fezolinetant: analysis of responders using pooled data from two phase 3 studies (SKYLIGHT 1 and 2).
Menopause
; 31(6): 512-521, 2024 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38626380
9.
Patient-reported outcomes validated in phase 3 clinical trials: a targeted literature review.
Curr Med Res Opin
; 39(7): 955-962, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37337959
10.
Preferences for Anaemia Treatment Attributes among Patients with Non-Dialysis-Dependent Chronic Kidney Disease.
Adv Ther
; 40(2): 641-657, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36449257
11.
Content Validity and Cognitive Debriefing of a Patient-Reported Outcome Instrument Evaluating Symptoms and Disease Impact in Patients with Geographic Atrophy.
Ophthalmol Ther
; 12(2): 1181-1193, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36781630
12.
Clinical factors for predicting cardiovascular risk, need for renal replacement therapy, and mortality in patients with non-dialysis-dependent stage 3-5 chronic kidney disease from the Salford Kidney Study.
J Nephrol
; 36(6): 1639-1649, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37289366
13.
Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination.
Vaccine
; 40(15): 2274-2281, 2022 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35292161
14.
Correction to: Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause.
Adv Ther
; 41(6): 2543, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38653952
15.
Management of hip fracture in adults: summary of NICE guidance.
BMJ
; 342: d3304, 2011 Jun 21.
Artigo
Inglês
| MEDLINE | ID: mdl-21693526